This is to inform you that the Corporate Briefing Session of Otsuka Pakistan Limited is scheduled to be held on the following date and time to brief the shareholders, prospective investors and analyst community about the historic and current financial performance upto June 30, 2023. This session will also apprise about current economic environment as well as future outlook of the Company.
DATE: October 2, 2023
DAY: Monday
TIME: Tentatively by 11:30 a.m.[after conclusssion of 35th Annual General Meeting (AGM)]
VANUE: at the Auditorium Hall, Institute of Chartered Accountants of Pakistan, Chartered Accountants Avenue, Clifton, Karachi
This briefing session will be held physically and virtually (via video‐link facility). Interested participants are requested to share their confirmation of participation by email to Company' Share Registrar i.e. M/s. CDC Share Registrar Services Limited at cdcsr@cdcsrsl.com or to the Company at secretarialcompliance@otsuka.pk at least 48 hours before the session time. The interested participants are also requested to provide the information as per the below table:
S. No. Name of Participant Cell (Whatsapp) Email Address Number
Type of Participation
(Physical / Online)
Name of Organization
Guidelines for participaiton through online:
Complete details of the video link sesssion will be sent to all the participants on their given email address &/or whatsapp number.
The participation will be able to login and participate through their smart phones &/or computer devices from their convenient location.
The login facility will be opened at 11:10 a.m. on October 2, 2023 enabling all the participants to join the session which will be started right after the conclusion of 35th AGM (tentatively by 11:30 a.m.)
Kindly join 5 to 10 minutes in advance of the scheduled time of the Corporate Briefing.
Please enter your name and the name of your respective institution in the above-mentioned format 'Full Name - Institution' while entering the meeting ID.
The briefing attendees would be requested to stay on "Mute" mode.
For the Q&A session, the briefing attedees would be requestd to type their questions or comments in the chat box so that the session administror can read them along with their name and response accordingly.
The attendees can also use the actions available on Zoom and raise a hand so that it becomes visible to the session administrator and the respective meeting attendee would subsequently be asked to go on "Unmute" mode and ask their question or mention their comments.
Sajid Ali Khan
Company Secretary
Attachments
Original Link
Original Document
Permalink
Disclaimer
Otsuka Pakistan Ltd. published this content on 25 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 August 2023 06:05:01 UTC.
Otsuka Pakistan Limited is a Pakistan-based company engaged in the manufacturing, marketing and distribution of intravenous (IV) infusions and trading in pharmaceutical products, nutritional foods, and medical equipment. It is primarily focused on IV solutions and has a range of electrolyte solutions, carbohydrate solutions, and clinical nutrition products. Its products include intravenous solutions, medical devices, clinical nutrition, therapeutic drugs and nutraceutical products. Its intravenous solutions include electrolyte solutions, standard solutions, ampoules, OTSUZOL, OTSUMOL infusion, and others. Its medical devices include urea breath test (UBT), Plasline solution, EUCATECH and Support C. Its clinical nutrition products include Aminoleban Oral, AMINOVEL 600, PAN-AMIN G, and AMINOLEBAN INJECTION. Its therapeutic drugs include Pletaal and Mucosta. Its nutraceutical products include ORTie, which is a special combination of dry salts and vitamin C to be mixed with safe water.
OTSUKA PAKISTAN LIMITED 
